<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9400372" created="28/03/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9400372</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="molecular_mechanism" sem="Other">Molecular mechanisms</term> of <term id="T2" lex="anoxia/reoxygenation-induced_neutrophil_adherence" sem="Other"><term id="A2" sem="Other">anoxia/reoxygenation</term>-induced <term id="A1" sem="Cell_natural">neutrophil</term> adherence</term> to <term id="T3" lex="cultured_endothelial_cell" sem="Cell_cultured">cultured endothelial cells</term>.</sentence>
<event KT="Other" id="E1">
<type class="Cell_adhesion"/>
<theme idref="T3"/>
<theme idref="A1"/>
<clue>Molecular mechanisms of anoxia/reoxygenation-induced neutrophil <clueType>adherence</clueType> <linkTheme>to</linkTheme> cultured endothelial cells.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="A2"/>
<clue>Molecular mechanisms of anoxia/reoxygenation-<clueType>induced</clueType> neutrophil adherence to cultured endothelial cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The objectives of this study were to (1) determine the time course of <term id="T4" lex="neutrophil_adhesion" sem="Other"><term id="A4" sem="Cell_natural">neutrophil</term> adhesion</term> to monolayers of <term id="T5" lex="human_umbilical_vein_endothelial_cell" sem="Cell_cultured">human umbilical vein endothelial cells</term> (<term id="T6" lex="HUVEC" sem="Cell_cultured">HUVECs</term>) that were exposed to 60 minutes of <term id="T7" lex="anoxia" sem="Other">anoxia</term> followed by 30 to 600 minutes of <term id="A3" sem="Other">reoxygenation</term> and (2) define the mechanisms responsible for both the early (minutes) and late (hours) <term id="T8" lex="hyperadhesivity" sem="Other">hyperadhesivity</term> of <term id="T9" lex="postanoxic_HUVEC" sem="Cell_cultured">postanoxic <term id="T10" lex="HUVEC" sem="Cell_cultured">HUVECs</term></term> to <term id="T11" lex="human_neutrophil" sem="Cell_natural">human neutrophils</term>.</sentence>
<event KT="Method" id="E3">
<type class="Artificial_process"/>
<theme idref="T6"/>
<theme idref="T7"/>
<clue>The objectives of this study were to (1) determine the time course of neutrophil adhesion to monolayers of human umbilical vein endothelial cells (HUVECs) that were <clueType>exposed</clueType> to <clueTime>60 minutes</clueTime> <linkCause>of</linkCause> anoxia followed by 30 to 600 minutes of reoxygenation and (2) define the mechanisms responsible for both the early (minutes) and late (hours) hyperadhesivity of postanoxic HUVECs to human neutrophils.</clue>
</event>
<event KT="Method" id="E4">
<type class="Artificial_process"/>
<theme idref="E3"/>
<theme idref="A3"/>
<clue>The objectives of this study were to (1) determine the time course of neutrophil adhesion to monolayers of human umbilical vein endothelial cells (HUVECs) that were <clueType>exposed</clueType> to 60 minutes of anoxia followed by <clueTime>30 to 600 minutes</clueTime> <linkCause>of</linkCause> reoxygenation and (2) define the mechanisms responsible for both the early (minutes) and late (hours) hyperadhesivity of postanoxic HUVECs to human neutrophils.</clue>
</event>
<event KT="Investigation" id="E5">
<type class="Cell_adhesion"/>
<theme idref="T6"/>
<theme idref="A4"/>
<clue><clueKT>The objectives of this study were to</clueKT> (1) <clueKT>determine</clueKT> the time course of neutrophil <clueType>adhesion</clueType> <linkTheme>to</linkTheme> monolayers of human umbilical vein endothelial cells (HUVECs) that were exposed to 60 minutes of anoxia followed by 30 to 600 minutes of reoxygenation and (2) define the mechanisms responsible for both the early (minutes) and late (hours) hyperadhesivity of postanoxic HUVECs to human neutrophils.</clue>
</event>
<event KT="Investigation" id="E6">
<type class="Cell_adhesion"/>
<theme idref="T11"/>
<theme idref="T9"/>
<clue><clueKT>The objectives of this study were to</clueKT> (1) determine the time course of neutrophil adhesion to monolayers of human umbilical vein endothelial cells (HUVECs) that were exposed to 60 minutes of anoxia followed by 30 to 600 minutes of reoxygenation and (2) <clueKT>define</clueKT> the mechanisms responsible for both the early (minutes) and late (hours) <clueType>hyperadhesivity</clueType> <linkTheme>of</linkTheme> postanoxic HUVECs <linkTheme>to</linkTheme> human neutrophils.</clue>
</event>
<sentence id="S3">The results clearly demonstrate that <term id="T12" lex="anoxia/reoxygenation" sem="Other"><term id="T13" lex="anoxia" sem="Other">anoxia</term>/reoxygenation</term> (<term id="T14" lex="A/R" sem="Other">A/R</term>) leads to a biphasic increase in <term id="T15" lex="neutrophil_adhesion" sem="Other"><term id="A5" sem="Cell_natural">neutrophil</term> adhesion</term> to <term id="T16" lex="HUVEC" sem="Cell_cultured">HUVECs</term>, with peak responses occurring at 30 minutes (<term id="A6" sem="Other">phase 1</term>) and 240 minutes (<term id="A7" sem="Other">phase 2</term>) after <term id="T17" lex="reoxygenation" sem="Other">reoxygenation</term>.</sentence>
<event KT="Other" id="E7">
<type class="Cell_adhesion"/>
<theme idref="A5"/>
<theme idref="T16"/>
<clue>The results clearly demonstrate that anoxia/reoxygenation (A/R) leads to a biphasic increase in neutrophil <clueType>adhesion</clueType> <linkTheme>to</linkTheme> HUVECs, with peak responses occurring at 30 minutes (phase 1) and 240 minutes (phase 2) after reoxygenation.</clue>
</event>
<event KT="Analysis" id="E8">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T14"/>
<clue>The results clearly <clueKT>demonstrate</clueKT> that anoxia/reoxygenation (A/R) <clueType>leads to</clueType> a biphasic <clueType>increase</clueType> <linkTheme>in</linkTheme> neutrophil adhesion to HUVECs, with peak responses occurring at 30 minutes (phase 1) and 240 minutes (phase 2) after reoxygenation.</clue>
</event>
<event KT="Other" Manner="High" id="E9">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<cause idref="T17"/>
<clue>The results clearly demonstrate that anoxia/reoxygenation (A/R) leads to a biphasic increase in neutrophil adhesion to HUVECs, <clueManner>with peak responses</clueManner> <clueType>occurring</clueType> <clueTime>at 30 minutes</clueTime> (phase 1) and 240 minutes (phase 2) <linkCause>after</linkCause> reoxygenation.</clue>
</event>
<event KT="Other" Manner="High" id="E10">
<type class="Positive_regulation"/>
<theme idref="A7"/>
<cause idref="T17"/>
<clue>The results clearly demonstrate that anoxia/reoxygenation (A/R) leads to a biphasic increase in neutrophil adhesion to HUVECs, <clueManner>with peak responses</clueManner> <clueType>occurring</clueType> <clueTime>at</clueTime> 30 minutes (phase 1) and <clueTime>240 minutes</clueTime> (phase 2) <linkCause>after</linkCause> reoxygenation.</clue>
</event>
<sentence id="S4"><term id="T18" lex="oxypurinol" sem="Organic_compound_other">Oxypurinol</term> and <term id="T19" lex="catalase" sem="Protein_family_or_group">catalase</term> inhibited <term id="T20" lex="phase-1_adhesion" sem="Other">phase-1 adhesion</term>, suggesting a role for <term id="T21" lex="xanthine_oxidase" sem="Protein_molecule">xanthine oxidase</term> and <term id="T22" lex="H2O2" sem="Inorganic_compound">H2O2</term>.</sentence>
<event id="E11">
<type class="Negative_regulation"/>
<theme idref="T20"/>
<cause idref="T18"/>
<clue>Oxypurinol and catalase <clueType>inhibited</clueType> phase-1 adhesion, suggesting a role for xanthine oxidase and H2O2.</clue>
</event>
<event id="E12">
<type class="Negative_regulation"/>
<theme idref="T20"/>
<cause idref="T19"/>
<clue>Oxypurinol and catalase <clueType>inhibited</clueType> phase-1 adhesion, suggesting a role for xanthine oxidase and H2O2.</clue>
</event>
<event CL="L2" KT="Analysis" id="E43" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T20"/>
<cause idref="T21"/>
<clue>Oxypurinol and catalase inhibited phase-1 adhesion, <clueKT><clueCL>suggesting</clueCL></clueKT> a <clueType>role</clueType> <linkCause>for</linkCause> xanthine oxidase and H2O2.</clue>
</event>
<event CL="L2" KT="Analysis" id="E44" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T20"/>
<cause idref="T22"/>
<clue>Oxypurinol and catalase inhibited phase-1 adhesion, <clueKT><clueCL>suggesting</clueCL></clueKT> a <clueType>role</clueType> <linkCause>for</linkCause> xanthine oxidase and H2O2.</clue>
</event>
<sentence id="S5">In comparison, <term id="T23" lex="platelet_activating_factor" sem="Protein_family_or_group">platelet activating factor</term> (<term id="T24" lex="PAF" sem="Protein_family_or_group">PAF</term>) contributed to both phases of <term id="T25" lex="neutrophil_adhesion" sem="Other"><term id="A20" sem="Cell_natural">neutrophil</term> adhesion</term>.</sentence>
<event id="E41">
<type class="Cell_adhesion"/>
<theme idref="A20"/>
<clue>In comparison, platelet activating factor (PAF) contributed to both phases of neutrophil <clueType>adhesion</clueType>.</clue>
</event>
<event id="E13">
<type class="Positive_regulation"/>
<theme idref="A6" idref1="E41"/>
<cause idref="T24"/>
<clue>In comparison, platelet activating factor (PAF) <clueType>contributed</clueType> <linkTheme>to</linkTheme> <corefTheme>both phases of neutrophil adhesion</corefTheme>.</clue>
</event>
<event id="E14">
<type class="Positive_regulation"/>
<theme idref="A7" idref1="E41"/>
<cause idref="T24"/>
<clue>In comparison, platelet activating factor (PAF) <clueType>contributed</clueType> <linkTheme>to</linkTheme> <corefTheme>both phases of neutrophil adhesion</corefTheme>.</clue>
</event>
<sentence id="S6"><term id="T26" lex="anti-intercellular_adhesion_molecule-1" sem="Protein_molecule">Anti-intercellular adhesion molecule-1</term> (<term id="T27" lex="ICAM-1" sem="Protein_molecule">ICAM-1</term>) and <term id="T28" lex="anti-P-selectin_antibody" sem="Protein_family_or_group">anti-P-selectin antibodies</term> (<term id="T29" lex="monoclonal_antibody" sem="Protein_family_or_group">monoclonal antibodies</term> [<term id="T30" lex="mAb" sem="Protein_family_or_group">mAbs</term>]) attenuated <term id="A8" sem="Other">phase-1</term> <term id="T31" lex="neutrophil_adhesion" sem="Other"><term id="A9" sem="Cell_natural">neutrophil</term> adhesion</term>, consistent with roles for constitutively expressed <term id="T32" lex="ICAM-1" sem="Protein_molecule">ICAM-1</term> and enhanced <term id="T33" lex="surface_expression" sem="Other">surface expression</term> of preformed <term id="T34" lex="P-selectin" sem="Protein_molecule">P-selectin</term>.</sentence>
<event id="E38">
<type class="Cell_adhesion"/>
<theme idref="A9"/>
<clue>Anti-intercellular adhesion molecule-1 (ICAM-1) and anti-P-selectin antibodies (monoclonal antibodies [mAbs]) attenuated <clueTime>phase-1</clueTime> neutrophil <clueType>adhesion</clueType>, consistent with roles for constitutively expressed ICAM-1 and enhanced surface expression of preformed P-selectin.</clue>
</event>
<event id="E15">
<type class="Negative_regulation"/>
<theme idref="A8" idref1="E38"/>
<cause idref="T27"/>
<clue>Anti-intercellular adhesion molecule-1 (ICAM-1) and anti-P-selectin antibodies (monoclonal antibodies [mAbs]) <clueType>attenuated</clueType> phase-1 neutrophil adhesion, consistent with roles for constitutively expressed ICAM-1 and enhanced surface expression of preformed P-selectin.</clue>
</event>
<event id="E16">
<type class="Negative_regulation"/>
<theme idref="E38"/>
<cause idref="T28"/>
<clue>Anti-intercellular adhesion molecule-1 (ICAM-1) and anti-P-selectin antibodies (monoclonal antibodies [mAbs]) <clueType>attenuated</clueType> phase-1 neutrophil adhesion, consistent with roles for constitutively expressed ICAM-1 and enhanced surface expression of preformed P-selectin.</clue>
</event>
<event KT="Other" id="E17">
<type class="Gene_expression"/>
<theme idref="T32"/>
<clue>Anti-intercellular adhesion molecule-1 (ICAM-1) and anti-P-selectin antibodies (monoclonal antibodies [mAbs]) attenuated phase-1 neutrophil adhesion, consistent with roles for constitutively <clueType>expressed</clueType> ICAM-1 and enhanced surface expression of preformed P-selectin.</clue>
</event>
<event KT="Other" id="E18">
<type class="Gene_expression"/>
<theme idref="T34"/>
<clue>Anti-intercellular adhesion molecule-1 (ICAM-1) and anti-P-selectin antibodies (monoclonal antibodies [mAbs]) attenuated phase-1 neutrophil adhesion, consistent with roles for constitutively expressed ICAM-1 and enhanced <clueLoc>surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> preformed P-selectin.</clue>
</event>
<event KT="Other" id="E19">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<clue>Anti-intercellular adhesion molecule-1 (ICAM-1) and anti-P-selectin antibodies (monoclonal antibodies [mAbs]) attenuated phase-1 neutrophil adhesion, consistent with roles for constitutively expressed ICAM-1 and <clueType>enhanced</clueType> surface expression of preformed P-selectin.</clue>
</event>
<event KT="Fact" id="E48">
<type class="Regulation"/>
<theme idref="E17"/>
<clue>Anti-intercellular adhesion molecule-1 (ICAM-1) and anti-P-selectin antibodies (monoclonal antibodies [mAbs]) attenuated phase-1 neutrophil adhesion, consistent with <clueType>roles</clueType> <linkCause>for</linkCause> constitutively expressed ICAM-1 and enhanced surface expression of preformed P-selectin.</clue>
</event>
<event KT="Fact" id="E49">
<type class="Regulation"/>
<theme idref="E19"/>
<clue>Anti-intercellular adhesion molecule-1 (ICAM-1) and anti-P-selectin antibodies (monoclonal antibodies [mAbs]) attenuated phase-1 neutrophil adhesion, consistent with <clueType>roles</clueType> <linkCause>for</linkCause> constitutively expressed ICAM-1 and enhanced surface expression of preformed P-selectin.</clue>
</event>
<sentence id="S7"><term id="A10" sem="Other">Phase-2</term> <term id="T35" lex="neutrophil_adhesion" sem="Other"><term id="A17" sem="Cell_natural">neutrophil</term> adhesion</term> was attenuated by an <term id="T36" lex="anti-E-selectin_mAb" sem="Protein_molecule">anti-<term id="A21" sem="Protein_molecule">E-selectin</term> mAb</term>, indicating a dominant role of this adhesion molecule in the <term id="T37" lex="late_phase_response" sem="Other">late phase response</term>.</sentence>
<event id="E39">
<type class="Cell_adhesion"/>
<theme idref="A17"/>
<clue><clueTime>Phase-2</clueTime> neutrophil <clueType>adhesion</clueType> was attenuated by an anti-E-selectin mAb, indicating a dominant role of this adhesion molecule in the late phase response.</clue>
</event>
<event id="E20">
<type class="Negative_regulation"/>
<theme idref="A10" idref1="E39"/>
<cause idref="T36"/>
<clue>Phase-2 neutrophil adhesion was <clueType>attenuated</clueType> <linkCause>by</linkCause> an anti-E-selectin mAb, indicating a dominant role of this adhesion molecule in the late phase response.</clue>
</event>
<event CL="L2" KT="Analysis" id="E42">
<type class="Regulation"/>
<theme idref="T37"/>
<cause idref="A21"/>
<clue>Phase-2 neutrophil adhesion was attenuated by an anti-E-selectin mAb, <clueKT><clueCL>indicating</clueCL></clueKT> a dominant <clueType>role</clueType> <linkCause>of</linkCause> this adhesion molecule <linkTheme>in</linkTheme> the late phase response.</clue>
</event>
<sentence id="S8">Pretreatment with <term id="T38" lex="actinomycin_D" sem="Organic_compound_other">actinomycin D</term> and <term id="T39" lex="cycloheximide" sem="Organic_compound_other">cycloheximide</term> or with competing <term id="T40" lex="ds-oligonucleotide" sem="Polynucleotide">ds-oligonucleotides</term> <term id="A25" sem="Polynucleotide">containing</term> the <term id="A26" sem="Polynucleotide"><term id="T41" lex="nuclear_factor-kappa_B" sem="Protein_complex">nuclear factor-kappa B</term></term> or <term id="A27" sem="Polynucleotide"><term id="T42" lex="activator_protein-1" sem="Protein_molecule">activator protein-1</term></term> <term id="A28" sem="Polynucleotide"><term id="T43" lex="cognate_DNA_sequence" sem="DNA_family_or_group">cognate DNA sequences</term></term> significantly attenuated <term id="T44" lex="phase-2_response" sem="Other">phase-2 response</term>, suggesting a role for <term id="T45" lex="de_novo_macromolecule_synthesis" sem="Other">de novo macromolecule synthesis</term>.</sentence>
<event KT="Method" id="E21">
<type class="Artificial_process"/>
<theme idref="T38"/>
<clue><clueType>Pretreatment</clueType> <linkTheme>with</linkTheme> actinomycin D and cycloheximide or with competing ds-oligonucleotides containing the nuclear factor-kappa B or activator protein-1 cognate DNA sequences significantly attenuated phase-2 response, suggesting a role for de novo macromolecule synthesis.</clue>
</event>
<event Manner="High" id="E34">
<type class="Negative_regulation"/>
<theme idref="T44"/>
<cause idref="E21"/>
<clue>Pretreatment with actinomycin D and cycloheximide or with competing ds-oligonucleotides containing the nuclear factor-kappa B or activator protein-1 cognate DNA sequences <clueManner>significantly</clueManner> <clueType>attenuated</clueType> phase-2 response, suggesting a role for de novo macromolecule synthesis.</clue>
</event>
<event KT="Method" id="E22">
<type class="Artificial_process"/>
<theme idref="T39"/>
<clue><clueType>Pretreatment</clueType> <linkTheme>with</linkTheme> actinomycin D and cycloheximide or with competing ds-oligonucleotides containing the nuclear factor-kappa B or activator protein-1 cognate DNA sequences significantly attenuated phase-2 response, suggesting a role for de novo macromolecule synthesis.</clue>
</event>
<event Manner="High" id="E35">
<type class="Negative_regulation"/>
<theme idref="T44"/>
<cause idref="E22"/>
<clue>Pretreatment with actinomycin D and cycloheximide or with competing ds-oligonucleotides containing the nuclear factor-kappa B or activator protein-1 cognate DNA sequences <clueManner>significantly</clueManner> <clueType>attenuated</clueType> phase-2 response, suggesting a role for de novo macromolecule synthesis.</clue>
</event>
<event KT="Method" id="E23">
<type class="Artificial_process"/>
<theme idref="T40" idref1="A25" idref2="A26" idref3="A28"/>
<clue><clueType>Pretreatment</clueType> with actinomycin D and cycloheximide or <linkTheme>with</linkTheme> competing ds-oligonucleotides containing the nuclear factor-kappa B or activator protein-1 cognate DNA sequences significantly attenuated phase-2 response, suggesting a role for de novo macromolecule synthesis.</clue>
<comment>TPS: A25</comment></event>
<event Manner="High" id="E36">
<type class="Negative_regulation"/>
<theme idref="T44"/>
<cause idref="E23"/>
<clue>Pretreatment with actinomycin D and cycloheximide or with competing ds-oligonucleotides containing the nuclear factor-kappa B or activator protein-1 cognate DNA sequences <clueManner>significantly</clueManner> <clueType>attenuated</clueType> phase-2 response, suggesting a role for de novo macromolecule synthesis.</clue>
</event>
<event KT="Method" id="E24">
<type class="Artificial_process"/>
<theme idref="T40" idref1="A25" idref2="A27" idref3="A28"/>
<clue><clueType>Pretreatment</clueType> with actinomycin D and cycloheximide or <linkTheme>with</linkTheme> competing ds-oligonucleotides containing the nuclear factor-kappa B or activator protein-1 cognate DNA sequences significantly attenuated phase-2 response, suggesting a role for de novo macromolecule synthesis.</clue>
<comment>TPS: A25</comment></event>
<event Manner="High" id="E37">
<type class="Negative_regulation"/>
<theme idref="T44"/>
<cause idref="E24"/>
<clue>Pretreatment with actinomycin D and cycloheximide or with competing ds-oligonucleotides containing the nuclear factor-kappa B or activator protein-1 cognate DNA sequences <clueManner>significantly</clueManner> <clueType>attenuated</clueType> phase-2 response, suggesting a role for de novo macromolecule synthesis.</clue>
</event>
<event KT="Other" id="E25">
<type class="Gene_expression"/>
<theme idref="T41"/>
<clue>Pretreatment with actinomycin D and cycloheximide or with competing ds-oligonucleotides containing the nuclear factor-kappa B or activator protein-1 cognate DNA sequences significantly attenuated phase-2 response, suggesting a role for de novo <corefTheme>macromolecule</corefTheme> <clueType>synthesis</clueType>.</clue>
</event>
<event KT="Other" id="E53">
<type class="Gene_expression"/>
<theme idref="T42"/>
<clue>Pretreatment with actinomycin D and cycloheximide or with competing ds-oligonucleotides containing the nuclear factor-kappa B or activator protein-1 cognate DNA sequences significantly attenuated phase-2 response, suggesting a role for de novo <corefTheme>macromolecule</corefTheme> <clueType>synthesis</clueType>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E45" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T37"/>
<cause idref="E25"/>
<clue>Pretreatment with actinomycin D and cycloheximide or with competing ds-oligonucleotides containing the nuclear factor-kappa B or activator protein-1 cognate DNA sequences significantly attenuated phase-2 response, <clueKT><clueCL>suggesting</clueCL></clueKT> a <clueType>role</clueType> <linkCause>for</linkCause> de novo macromolecule synthesis.</clue>
<comment>NO COREFTHEME</comment></event>
<event CL="L2" KT="Analysis" id="E46" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T37"/>
<cause idref="T53"/>
<clue>Pretreatment with actinomycin D and cycloheximide or with competing ds-oligonucleotides containing the nuclear factor-kappa B or activator protein-1 cognate DNA sequences significantly attenuated phase-2 response, <clueKT><clueCL>suggesting</clueCL></clueKT> a <clueType>role</clueType> <linkCause>for</linkCause> de novo macromolecule synthesis.</clue>
<comment>NO COREFTHEME</comment></event>
<sentence id="S9">Surface expression of <term id="T46" lex="ICAM-1" sem="Protein_molecule">ICAM-1</term>, <term id="T47" lex="P-selectin" sem="Protein_molecule">P-selectin</term>, and <term id="T48" lex="E-selectin" sem="Protein_molecule">E-selectin</term> on <term id="T49" lex="HUVEC" sem="Cell_cultured">HUVECs</term> correlated with the <cons id="T50" lex="(AND phase-1_neutrophil_adhesion_response phase-2_neutrophil_adhesion_response)" sem="(AND Other Other)"><frag id="F1"><term id="A13" sem="Other">phase</term></frag><frag id="F2"><term id="A14" sem="Other">-1</term></frag> and <frag id="F3"><term id="A15" sem="Other">-2</term></frag> <frag id="F4"><term id="A16" sem="Other"><term id="A30" sem="Cell_natural">neutrophil</term> adhesion responses</term></frag></cons>.</sentence>
<event KT="Other" id="E26">
<type class="Gene_expression"/>
<theme idref="T46"/>
<clue><clueLoc>Surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> ICAM-1, P-selectin, and E-selectin <clueLoc>on HUVECs</clueLoc> correlated with the phase-1 and -2 neutrophil adhesion responses.</clue>
</event>
<event KT="Other" id="E27">
<type class="Gene_expression"/>
<theme idref="T47"/>
<clue><clueLoc>Surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> ICAM-1, P-selectin, and E-selectin <clueLoc>on HUVECs</clueLoc> correlated with the phase-1 and -2 neutrophil adhesion responses.</clue>
</event>
<event KT="Other" id="E28">
<type class="Gene_expression"/>
<theme idref="T48"/>
<clue><clueLoc>Surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> ICAM-1, P-selectin, and E-selectin <clueLoc>on HUVECs</clueLoc> correlated with the phase-1 and -2 neutrophil adhesion responses.</clue>
</event>
<event KT="Analysis" id="E29">
<type class="Correlation"/>
<theme idref="E26"/>
<theme idref="A13" idref1="A14" idref2="A16"/>
<clue>Surface expression of ICAM-1, P-selectin, and E-selectin on HUVECs <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> the phase-1 and -2 neutrophil adhesion responses.</clue>
</event>
<event KT="Analysis" id="E30">
<type class="Correlation"/>
<theme idref="E27"/>
<theme idref="A13" idref1="A15" idref2="A16"/>
<clue>Surface expression of ICAM-1, P-selectin, and E-selectin on HUVECs <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> the phase-1 and -2 neutrophil adhesion responses.</clue>
</event>
<event KT="Other" id="E47">
<type class="Cell_adhesion"/>
<theme idref="A30"/>
<clue>Surface expression of ICAM-1, P-selectin, and E-selectin on HUVECs correlated with the phase-1 and -2 neutrophil <clueType>adhesion</clueType> responses.</clue>
</event>
<sentence id="S10">Collectively, these findings indicate that <term id="T51" lex="A/R" sem="Other">A/R</term> elicits a <term id="T52" lex="two-phase_neutrophil-endothelial_cell_adhesion_response" sem="Other">two-phase <term id="A18" sem="Cell_natural">neutrophil</term>-<term id="A22" sem="Cell_natural">endothelial cell</term> adhesion response</term> that involves <term id="T53" lex="transcription-independent_surface_transcription" sem="Other"><term id="A23" sem="Other">transcription</term>-independent</term> and <term id="T54" lex="transcription-dependent_surface_expression" sem="Other"><term id="A24" sem="Other">transcription</term>-dependent <term id="T55" lex="surface_expression" sem="Other">surface expression</term></term> of different <term id="T56" lex="endothelial_cell_adhesion_molecule" sem="Protein_family_or_group">endothelial cell adhesion molecules</term>.</sentence>
<event CL="L2" KT="Analysis" id="E31">
<type class="Positive_regulation"/>
<theme idref="E40"/>
<cause idref="T51"/>
<clue>Collectively, these findings <clueKT><clueCL>indicate</clueCL></clueKT> that A/R <clueType>elicits</clueType> a two-phase neutrophil-endothelial cell adhesion response that involves transcription-independent and transcription-dependent surface expression of different endothelial cell adhesion molecules.</clue>
</event>
<event KT="Other" id="E32">
<type class="Gene_expression"/>
<theme idref="T56"/>
<clue>Collectively, these findings indicate that A/R elicits a two-phase neutrophil-endothelial cell adhesion response that involves transcription-independent and transcription-dependent <clueLoc>surface</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> different endothelial cell adhesion molecules.</clue>
</event>
<event KT="Other" Polarity="Negative" assertion="non-exist" id="E50">
<type class="Regulation"/>
<theme idref="E32"/>
<cause idref="A23"/>
<clue>Collectively, these findings indicate that A/R elicits a two-phase neutrophil-endothelial cell adhesion response that involves transcription-<clueType><cluePolarity>independent</cluePolarity></clueType> and transcription-dependent surface expression of different endothelial cell adhesion molecules.</clue>
</event>
<event KT="Other" id="E51">
<type class="Regulation"/>
<theme idref="E32"/>
<cause idref="A24"/>
<clue>Collectively, these findings indicate that A/R elicits a two-phase neutrophil-endothelial cell adhesion response that involves transcription-independent and transcription-<clueType>dependent</clueType> surface expression of different endothelial cell adhesion molecules.</clue>
</event>
<event KT="Other" id="E33">
<type class="Correlation"/>
<theme idref="E31"/>
<theme idref="E50"/>
<clue>Collectively, these findings indicate that A/R elicits a two-phase neutrophil-endothelial cell adhesion response that <clueType>involves</clueType> transcription-independent and transcription-dependent surface expression of different endothelial cell adhesion molecules.</clue>
</event>
<event KT="Other" id="E52">
<type class="Correlation"/>
<theme idref="E31"/>
<theme idref="E52"/>
<clue>Collectively, these findings indicate that A/R elicits a two-phase neutrophil-endothelial cell adhesion response that <clueType>involves</clueType> transcription-independent and transcription-dependent surface expression of different endothelial cell adhesion molecules.</clue>
</event>
<event KT="Other" id="E40">
<type class="Cell_adhesion"/>
<theme idref="A18"/>
<theme idref="A22"/>
<clue>Collectively, these findings indicate that A/R elicits a two-phase neutrophil-endothelial cell <clueType>adhesion</clueType> response that involves transcription-independent and transcription-dependent surface expression of different endothelial cell adhesion molecules.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
